IDG Capital Backs Shenzhen-Based Biotech Firm Yuce Bio In Series B Round

Login to View

Shenzhen-based Biotech firm Yuce Biological Technology has completed a series B round led by IDG Capital, as biotech booms in China.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in